Concourse Financial Group Securities’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 5071 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 6016 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 6007 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 6031 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 6031 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 5968 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 5851 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 5718 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 5510 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 5503 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 5318 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 5318 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 5217 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 5235 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 5097 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 4936 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 4800 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 4669 |
|